Ikeda R, Yoshida S, Chen W, Fujiwara M, et al. Quantitative Evaluation of Pharmacologic Synergy for Neoadjuvant Enfortumab Vedotin Plus Pembrolizumab in Muscle-Invasive Bladder Cancer: A Copula-Based Secondary Analysis. Int J Urol 2026;33:e70667.
PMID: 42843984